Sinobiopharma, Inc. (fka SNBP)

[pappy]

"looks like junk to me"

Everyone has their own opinion.

Speculative yes but not junk.

This company has the best flagship product in its space & has many promising drugs approved or waiting approval.

Management is very well versed in developing & marketing new drugs.

Growth in recent qtrs has accelerated with eps growth expected to show about 50% growth over the next few years in spite a large increase in shares outstanding & cashflow + shareholder equity is also growing rapidly.

If share count starts to increase without a worh while increase in eps & shareholder equity then I would agree with your opinion.

To date that has not been the case.